Categories Uncategorized

Patent Suggests Apple Is Working on Smart Biomedical Glasses

It is commonly known that Apple is working on bettering its offerings in the wellness and health category. The company was recently awarded a patent that indicates that the firm is taking its approach into health a step further with a new invention: biomedical smart glasses.

Spotted by Patently Apple, the new patent describes this invention as a head-mounted display device that can monitor certain head movements such as nodding one’s head as well as facial gestures such as closing and opening mouths. The device can also be used with other health devices, including the Apple Watch. This ability will provide users with important information concerning their health. The patent focuses on computer-readable media that can monitor the user of the head-wearable electronic device using multiple light-sensing assemblies and systems methods.

As many may find the patent highly technical, allow us to simplify it. The patent discusses a pair of smart glasses that feature several sensors such as stress sensors, electrocardiography sensors, electric field sensors, thermal sensors, health-related optical sensors and the like. These sensors can be utilized in monitoring various metrics, gestures and movements such as winking, squinting, blinking, eyes widening, eye rolling, eyebrow raising, smiling, chewing and more.

Additionally, the patent states that the system can also monitor internal vocalizations such as uh-huh and mmm-hmm, humming, flaring nostrils, jaw motions, inaudible cues, mouth opening and speaking or other external-language vocalization.

In addition, many may find it interesting to learn that the patent states that the system can be used to understand brain functions, including thoughts and emotions. By working in collaboration with other health gadgets, the device may be used to monitor biometric characteristics such as temperature, sweating, oxygen saturation and heart rate. The device is then able to alert its users about the vital information it collects.

This information can then be utilized for a wide range of health purposes, including providing health providers and users with important data.

Furthermore, the display characteristics of the glasses would modify according to an individual’s medical needs. This improvement in the design would allow an individual with a defect in their vision to use these smart glasses without having to wear eyeglasses or contact lenses at the same time. The latest information that was leaked puts the product launch for the middle of next year, with the expected market price of about $500 for these smart glasses.

The biomedical field is witnessing the growing use of artificial intelligence, analytics and smart devices. One company you need to watch in this space is DarioHealth Corp. (NASDAQ: DRIO). The company focuses on using smartphone-based digital therapeutics to help patients with chronic illnesses better manage their conditions by making lifestyle changes and tracking different parameters of their health.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Parkinson’s-Gut Bacteria Link Suggests Surprisingly Simple Treatment Option

For long, researchers have posited that a link between our brain and gut contributes to…

3 hours ago

Breakthrough Treatment for Lung Cancer Uses Mitochondria to Supercharge Immune Cells

Researchers in China have discovered a way to supercharge the treatment of lung cancer by…

4 days ago

Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF): The Cancer Detection Revolution That Could Make Breast Cancer Deaths Preventable

Izotropic’s IzoView Breast CT Imaging System represents a breakthrough in dedicated breast imaging technology, addressing…

4 days ago

Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) Advancing Next-Gen Breast Cancer Imaging

Breast cancer continues to be the most commonly diagnosed cancer among U.S. women, excluding nonmelanoma…

5 days ago

How to Rebuild Trust in the US Healthcare System

A recent survey undertaken by Gallup in 2025 found that since 2021, there has been…

5 days ago

Lantern Pharma Inc. (NASDAQ: LTRN) Completes Japanese Enrollment for LP-300 Phase 2 HARMONIC(TM) Trial Ahead of Schedule

The trial targets never-smoker non-small cell lung cancer (“NSCLC”) patients, a group with limited treatment…

5 days ago